Status:

UNKNOWN

Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba

Lead Sponsor:

Jean-François Démonet

Collaborating Sponsors:

University of Lausanne Hospitals

Conditions:

Subjective Cognitive Decline

Cognitive Performance

Eligibility:

All Genders

55-80 years

Phase:

NA

Brief Summary

The objective of this study is to simultaneously establish the metrological characteristics of the new executive function markers (decision making and multiple flow management) derived from repeated E...

Detailed Description

This study is a single-center, randomized clinical trial testing the effects of Ginkgo biloba extracts versus placebo on event related potential ERP registration measurements in Electroencephalography...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Signed consent form
  • men and women
  • 60 to 80 years old
  • Diagnostic of Subjective complain
  • Understanding the 2 Hold-Release tasks in ERP
  • Exclusion Criteria:
  • Montreal Cognitive Evaluation Score (MoCA) \<24
  • Overall Clinical Dementia Rating (CDR) score \> 0.5
  • Scores of the Hospital Anxiety and Depression Scale (HADS): HADS-A (Anxiety) \> 8 and/or HADS-D (Depression) \> 8
  • Mild Cognitive Impairment (MCI) or dementia
  • Contraindication to MRI
  • Atrophy of any region of the brain as seen in the T1 volumetric MRI sequence
  • Any uncontrolled somatic or psychiatric condition
  • Bleeding disorders, and/or taking medications that increase the risk of bleeding,
  • Hypersensitivity to Ginkgo biloba or any of its excipients
  • Lactose intolerance
  • Treatment with barbiturates and/or neuroleptics
  • Ongoing treatment with Ginkgo biloba derivatives (a period of 2 months without treatment before inclusion is required

Exclusion

    Key Trial Info

    Start Date :

    September 9 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 31 2024

    Estimated Enrollment :

    16 Patients enrolled

    Trial Details

    Trial ID

    NCT04121728

    Start Date

    September 9 2019

    End Date

    May 31 2024

    Last Update

    January 11 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Centre Leenaards de la mémoire (CLM) CHUV

    Lausanne, Canton of Vaud, Switzerland, 1011